Research, Articles

on the use of Dihydroquercetin and Arabinogalactan

This page summarizes studies that confirm that dihydroquercetin and arabinogalactan are able to resist the development of COVID-19.


"Does Arabinogalactan Improve Immune Functioning? Clinical Trials Review"

About: Recent human studies have shown that arabinogalactan can increase the body's resistance to colds and has an immunostimulating effect.
Article language: ENG


"Influence of Arabinogalactan on the incidence of respiratory diseases"

About: Research on the ability of arabinogalactan to prevent the development of colds and on the possibility of using it as a prophylactic agent.

Article language : ENG


"Arabinogalactan extract improves antibody response to pneumonia vaccine"

About: The study found that taking arabinogalactan is able to increase the antibody response to the level of 23-valent vaccines against pneumococcal infection (PNEUMO 23).

Article language: ENG


Dihydroquercetin is an assistant in the fight against coronavirus. Research University of Basel, Switzerland

About: The study identified 11 compounds that can have a positive effect on patients with COVID-19, one of which is dihydroquercetin

Article language: RUS

Robios translation of the COVID-19 Intensive Care Protocol developed by Paul Marik, M.D., Head of Pulmonology and Critical Care Unit, East Virginia School of Medicine

Language: RUS


"Prospects for the use of regulators of oxidative stress in the comprehensive treatment of the novel Coronavirus Disease 2019 (COVID-19) and its complications"

About: The study looks at the prospects for the use of several components, one of which is dihydroquercetin, for the treatment and recovery from COVID-19.
Article language: ENG

Come to us

Robios company

Serpukhov, Northern Highway 16

142204 Russia


Tel .: +7 (903) 612 64 79

Fax: +7 (495) 000 00 00

Contact Information

© 2023 "Business Solutions". Proudly created with

  • иконка facebook
  • Иконка Twitter с прозрачным фоном
  • белая иконка googleplus